Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study
出版年份 2016 全文链接
标题
Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study
作者
关键词
-
出版物
PSYCHOLOGICAL MEDICINE
Volume 46, Issue 09, Pages 1909-1921
出版商
Cambridge University Press (CUP)
发表日期
2016-04-06
DOI
10.1017/s0033291716000398
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Replication and contradiction of highly cited research papers in psychiatry: 10-year follow-up
- (2015) Aran Tajika et al. BRITISH JOURNAL OF PSYCHIATRY
- Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8years later
- (2015) Joseph Ventura et al. SCHIZOPHRENIA RESEARCH
- Treatment resistant schizophrenia: a comprehensive survey of randomised controlled trials
- (2014) Diarmid Sinclair et al. BMC Psychiatry
- Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
- (2014) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine
- (2014) Maria Rosaria A Muscatello et al. EXPERT OPINION ON PHARMACOTHERAPY
- Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis
- (2014) S. Veerman et al. PHARMACOPSYCHIATRY
- Non-Glutamatergic Clozapine Augmentation Strategies: A Review and Meta-Analysis
- (2014) S. Veerman et al. PHARMACOPSYCHIATRY
- The Glutamate Hypothesis: A Pathogenic Pathway from which Pharmacological Interventions have Emerged
- (2014) S. Veerman et al. PHARMACOPSYCHIATRY
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Memantine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia
- (2013) Farzin Rezaei et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Two subdomains of negative symptoms in psychotic disorders: Established and confirmed in two large cohorts
- (2013) Edith Liemburg et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
- (2012) Shunske Tanahashi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
- (2012) Jung Goo Lee et al. Psychiatry Investigation
- Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment
- (2012) Sefa Vayısoğlu et al. SCHIZOPHRENIA RESEARCH
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
- (2010) Joshua T. Kantrowitz et al. BRAIN RESEARCH BULLETIN
- Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
- (2010) Tyler A Lesh et al. NEUROPSYCHOPHARMACOLOGY
- Assessing cognitive function in clinical trials of schizophrenia
- (2010) Jennifer H. Barnett et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Homeostatic regulation of glutamatergic transmission by dopamine D4 receptors
- (2010) E. Y. Yuen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia
- (2009) David de Lucena et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity
- (2008) Keith H. Nuechterlein et al. AMERICAN JOURNAL OF PSYCHIATRY
- Memantine for the Treatment of Alzheimer???s Disease
- (2008) Martin R Farlow et al. DRUG SAFETY
- Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
- (2008) H Afshar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
- (2008) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation